Aug 5, 2026 07:21AM
Aug 5, 2026 06:59AM
May 27, 2026 08:00AM
May 27, 2026 08:00AM
May 5, 2026 07:46AM
May 5, 2026 06:59AM
Mar 10, 2026 08:42AM Q32 Bio (QTTB) Tops Q4 EPS by 458c
Mar 10, 2026 06:59AM
Nov 13, 2025 07:42AM
Nov 13, 2025 06:59AM
Aug 6, 2025 07:59AM
Aug 6, 2025 06:59AM
May 8, 2025 04:46PM
May 8, 2025 06:59AM Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
Mar 11, 2025 04:53PM
Mar 11, 2025 06:59AM
Nov 7, 2024 06:59AM
Oct 14, 2024 06:59AM
Aug 8, 2024 09:22AM
Aug 8, 2024 06:59AM
Jul 9, 2024 06:59AM Q32 Bio (QTTB) Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis
Jul 9, 2024 06:59AM
Jul 1, 2024 06:59AM
Jul 1, 2024 06:59AM
May 9, 2024 06:59AM
Apr 3, 2024 07:02AM
Apr 3, 2024 07:00AM
Mar 25, 2024 04:15PM Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million

1,218,232 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All